FMP
NASDAQ
4.71 USD
0.04 (0.849%)
Mr. Lloyd Mitchell Segal
Healthcare
Biotechnology
https://www.reparerx.com
NASDAQ
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that focuses on genomic instability, including DNA damage repair. Its lead product candidate is RP-3500, an oral small molecule inhibitor for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. It is also developing RP-6306, which is under Phase I clinical trial for tumors with genetic alterations characterized by CCNE1 ...
0001808158
US7602731025
760273102
7210 Frederick-Banting
857 412 7018
CA
179
Jun 19, 2020
0001808158
NASDAQ
Biotechnology
Healthcare
760273102
US7602731025
CA
4.71
0.61
154.16k
198.68M
-
3.08-13.85
0
-
-
-
-
-2.11
-
https://www.reparerx.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.